Affimed NV (NASDAQ:AFMD)
| 1.64 Delayed Data As of Apr 02 |  +0.05 / +3.14%Today’s Change | 1.42 Today|||52-Week Range 4.30 | -40.15% Year-to-Date |
Latest AFMD News | Press Releases
No recent news for Affimed NV.
Today’s Trading
| Previous close | 1.59 |
| Today’s open | 1.67 |
| Day’s range | 1.55 - 1.69 |
| Volume | 82,355 |
| Average volume (3 months) | 916,790 |
| Market cap | $100.1M |
Data as of 3:59pm ET, 04/02/2020
Growth & Valuation
| Earnings growth (last year) | +51.28% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +1,135.09% |
| P/E ratio | NM |
| Price/Sales | 6.72 |
| Price/Book | 2.13 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SVRASavara Inc | -0.16 | -8.00% |
| LOGCLogicBio Therapeutic... | -0.13 | -2.95% |
| GMDAGamida Cell Ltd | -0.07 | -2.29% |
| MBIOMustang Bio Inc | +0.15 | +6.44% |
Data as of 4:00pm ET, 04/02/2020
Financials
| Next reporting date | May 13, 2020 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $28.0M |
| Annual profit (last year) | -$23.0M |
| Net profit margin | -82.06% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Heidelberg, Baden Wuerttemberg |
Forecasts
